Belgium· BE-AMP-SAM083115-00

Microlut 0.03 mg

A levonorgestrel product containing levonorgestrel, registered in Belgium by Bayer. The same ATC class is registered in 2 of our 19 countries.

ATC G03AC03

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedMicrolut 0.03 mgATCG03AC03REGISTER NO.BE-AMP-SAM083115-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Levonorgestrel is registered in 2 of 19 countries.

Countries holding a registration under ATC G03AC03 (levonorgestrel), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 2 of them publish a price we can compare per daily dose

Levonorgestrel · ATC G03AC03

2 / 19 countries

  • Belgiumprice
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Levonorgestrel
Manufacturer
Bayer
Country
Belgium (BE)
ATC code
G03AC03
ATC class
Levonorgestrel
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    0059964
  • be_apb
    0733154

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

245 interactions on record for levonorgestrel.

Graded by severity as the source publishes them — 16 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Levonorgestrel · interactions on record

245 records

  • 16 severe
  • 143 moderate
  • 7 minor
  • 56 info

Most severe, free to view

  • Tranexamic acidB02AA02severe
  • GriseofulvinD01AA08severe
  • GriseofulvinD01BA01severe
  • AcitretinD05BB02severe

23 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Levonorgestrel in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levonorgestrel products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Jaydess, Kyleena
  • Bulgaria · Ескапел, Ескапеле
  • Cyprus · Levosert, Levosert One
  • Czechia · Egianti, Escapelle
  • Germany · 28 Mini, Jaydess
  • Denmark · Frivelle, Jaydess
  • Estonia · Avodele, Donasert
  • Spain · Cumbran, Jaydess
  • Finland · Jadelle, Jadelle Sine Inserter
  • France · Donasert, Jaydess
  • United Kingdom (Northern Ireland) · Almus Emergency Contraceptive, Emerres
  • Greece · Levonorgestrel Richter, Mirena
  • Croatia · Escapelle, Levosert
  • Hungary · Empil, Escapelle
  • Ireland · Jaydess, Kyleena
  • Iceland · Jaydess, Kyleena
  • Italy · Benilexa, Escapelle
  • Lithuania · Avodele, Cadele
  • Luxembourg · Jaydess, Levonortis
  • Latvia · Avodele, Escapelle
  • Malta · Escapelle, Jaydess
  • Netherlands · Isteranda, Kruidvat Noodanticonceptie
  • Norway · Jaydess, Kyleena
  • Poland · Escapelle, Kyleena
  • Portugal · Cumbran, Gestanor
  • Romania · Apreg, Emergana
  • Sweden · Frivelle, Jaydess
  • Slovenia · Escapelle, Kyleena
  • Slovakia · Apreg, Escapelle

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5eb91c0d-63ed-4021-9cda-5a736b07c142
GET /v1/drugs/5eb91c0d-63ed-4021-9cda-5a736b07c142?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Coated tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Microlut 0.03 mg",
  "name_fr": "Microlut 0.03 mg",
  "name_nl": "Microlut 0.03 mg",
  "amp_code": "SAM083115-00",
  "strengths": [
    "30.0000",
    "30.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Levonorgestrel"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Levonorgestrel",
  "authorisation_numbers": [
    "BE083115"
  ]
}

See everything about levonorgestrel.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.